Lipoprotein(a) and lipid screening for UCF primary care patients
Prospective Screening for Elevated Lipoprotein(a) in an Adult Primary Care Population
University of Central Florida · NCT07579325
This pilot will test how common high Lipoprotein(a) is among adults receiving care at UCF primary care clinics by measuring Lp(a), HDL, LDL, and a standard lipid panel.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Central Florida (other) |
| Locations | 1 site (Orlando, Florida) |
| Trial ID | NCT07579325 on ClinicalTrials.gov |
What this trial studies
This pilot observational study will estimate the prevalence of elevated Lipoprotein(a) in an adult primary care population served by UCF Health. Participants will undergo a single venipuncture to measure Lp(a) and other atherogenic lipid markers such as HDL and LDL. The study will describe the distribution of these markers across the cohort and identify how frequently elevated Lp(a) occurs. Findings will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.
Who should consider this trial
Good fit: Adults aged 18 or older who receive care at a UCF Health primary care clinic and can provide informed consent and HIPAA authorization.
Not a fit: People who are pregnant, not patients at UCF primary care clinics, or who cannot safely undergo venipuncture are unlikely to benefit from participating.
Why it matters
Potential benefit: If successful, results could help primary care clinicians identify patients with elevated Lp(a) who may need closer cardiovascular risk management.
How similar studies have performed: Prior population-based research has shown that elevated Lp(a) is a cardiovascular risk factor and that prevalence varies by population, but routine primary care screening has not been widely implemented.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Receiving care at UCF Health primary care clinic * Able to understand and provide informed consent and HIPAA authorization Exclusion Criteria: * Patient self discloses any medical condition that would make venipuncture unsafe * Pregnant women
Where this trial is running
Orlando, Florida
- University of Central Florida — Orlando, Florida, United States (RECRUITING)
Study contacts
- Principal investigator: Stephanie Perez, MSN, MBA, ARNP, CLS, BHCN — University of Central Florida
- Study coordinator: Amoy Fraser, PhD, CCRP, PMP
- Email: Amoy.Fraser@UCF.edu
- Phone: 14072668742
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lipoprotein, lipoprotein, HDL and LDL, HDL, LDL, lipid Panel